Immunotherapy company 3T Biosciences has named John Leonard, MD, to its board of directors.
Currently, Dr. Leonard serves as president and CEO of Intellia Therapeutics. Prior to Intellia, Dr. Leonard was the chief scientific officer and global vice president of research and development at AbbVie, according to an Oct. 25 3T news release.
Dr. Leonard has worked on HIV inhibitors Norvir and Kaletra as well as the top-selling arthritis pain reliever Humira.